CRISPR‐Based Point‐of‐Care Diagnostics: Cas12, Cas13, Cas14, Microfluidics, and Comparison with PCR
Conventional molecular diagnostics, particularly polymerase chain reaction (PCR), remain the gold standard for pathogen detection but are often unsuitable for rapid point‐of‐care (POC) testing because they require specialized equipment and laboratory infrastructure. CRISPR‐Cas systems have emerged as powerful alterna...